DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

Meridian Bioscience Q1 Adj. EPS $0.1 Beats $0.07 Estimate, Sales $47.4M Miss $48.9M Estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.1 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. This is a 50 percent decrease over earnings of $0.2 per share from the

Benzinga · 02/07/2020 12:31

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.1 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. This is a 50 percent decrease over earnings of $0.2 per share from the same period last year. The company reported quarterly sales of $47.4 million which missed the analyst consensus estimate of $48.9 million by 3.07 percent. This is a 7.93 percent decrease over sales of $51.48 million the same period last year.